During the past decade, Kyiv Regional Oncological Dispensary conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyiv Regional Oncological Dispensary" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Kyiv Regional Oncological Dispensary" are "Early Breast Cancer" (2 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Kyiv Regional Oncological Dispensary" in a lesser frequency.

Most popular intervention types in "Kyiv Regional Oncological Dispensary" are "Drug" (8 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Giredestrant" (3 trials), "Atezolizumab" (2 trials), "LHRH Agonist" (2 trials), "Paclitaxel" (2 trials) and "Abiraterone acetate (AA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kyiv Regional Oncological Dispensary" are 5 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kyiv Regional Oncological Dispensary". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kyiv Regional Oncological Dispensary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kyiv Regional Oncological Dispensary, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".